Key result
Accelerated hypertension was associated with a shorter estimated mean survival (18 years) compared to other hypertensives (21 years), with nearly 50% of deaths due to acute myocardial infarction.
Why the study?
What are the patterns of mortality and clinical factors affecting outcome in treated patients with accelerated hypertension compared to other hypertensives?
Cohort (n=3,928)
No
What are the patterns of mortality and clinical factors affecting outcome in treated patients with accelerated hypertension compared to other hypertensives?
Treated patients with accelerated hypertension have a slightly worse prognosis than other hypertensives, but can survive for a considerable period with suitable care.
No takes yet. Share an insight, caveat, or question.
May support enhanced surveillance in accelerated hypertension; leaves open whether targeted interventions reduce AMI mortality.
Webster et al. (1993) conducted a cohort in Accelerated hypertension (n=3,928). Accelerated hypertension vs. Other hypertensives was evaluated on Systolic and diastolic pressure, length of time from referral to death or censor date, and cause of death. Accelerated hypertension was associated with a shorter estimated mean survival (18 years) compared to other hypertensives (21 years), with nearly 50% of deaths due to acute myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: